News
How to design and launch a successful Clinical Trial Manufacturing.
Patient associations are shaping trials, asking hard questions, and demanding realistic timelines for treatment delivery.
1d
GlobalData on MSNNMPA approves BBM and Takeda China’s haemophilia B therapyBelief BioMed (BBM) and Takeda China have announced China’s National Medical Products Administration's (NMPA) approval for ...
A drug used to treat a rare inherited disease has been found to make human blood toxic to malaria-carrying mosquitoes. It ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Despite the challenges, including what CSL CEO Paul McKenzie has described as a fragmented U.S. healthcare system, the blood ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...
In case you had any doubts, the golden age of white-collar crime is upon us. The Justice Department announced on Monday that ...
Lexeo Therapeutics’ gene therapy provides a healthy version of the frataxin gene, which is critical for energy production in ...
Pacira Biosciences leads in non-opioid pain relief with Exparel & upcoming knee osteoarthritis therapy. Click here to read my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results